原发性硬化性胆管炎：患者指南

Overview

Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare autoimmune disorder in which the immune system mistakenly attacks the myelin sheath—the protective covering around peripheral nerves. This leads to inflammation, slowed nerve signals, and progressive weakness or sensory problems that develop over at least 8 weeks. Unlike Guillain-Barré syndrome (which is acute), CIDP is chronic and can follow a relapsing-remitting or steadily progressive course. It affects people of any age but is more common in adults, especially men. With timely treatment, many people regain significant function and lead active lives.

Signs & Symptoms

Symptoms usually start gradually and may worsen over months. They often affect both sides of the body and can involve arms, legs, or both.

• Progressive muscle weakness, especially in the legs and feet, making walking, climbing stairs, or rising from a chair difficult
• Numbness, tingling, or pins-and-needles sensations (paresthesia) in hands and feet
• Loss of reflexes (areflexia)
• Fatigue and reduced endurance
• Balance problems or unsteadiness that can lead to falls
• In some cases, pain, tremor, or difficulty with fine motor tasks like buttoning clothes
• Rarely, breathing or swallowing difficulties if more severe

Causes & Risk Factors

The exact cause of CIDP is not fully known. It is considered an autoimmune condition in which the immune system targets myelin on peripheral nerves. There is no single trigger, though preceding infections or other immune events are sometimes reported. CIDP is not contagious and is not caused by lifestyle factors alone.

• Possible risk factors include older age (peak in 40s–60s), male sex, and certain other autoimmune conditions
• Rare associations with diabetes, monoclonal gammopathies, or other immune disorders
• No strong evidence of direct inheritance; most cases are sporadic
• Stress, infection, or surgery may occasionally precede a flare in susceptible people

Diagnosis

Diagnosis relies on clinical history, neurological exam, and supporting tests. There is no single definitive blood test. A neurologist experienced in neuromuscular disorders usually leads the evaluation. Early and accurate diagnosis is important because treatment works best when started promptly.

• Nerve conduction studies and electromyography (EMG) to show demyelination patterns (slowed conduction, conduction block)
• Lumbar puncture (spinal tap) to check for elevated protein in cerebrospinal fluid with few white cells
• Blood tests to rule out other causes of neuropathy (vitamin deficiencies, diabetes, infections, monoclonal proteins)
• MRI of the spine or nerve roots in some cases to look for nerve root enlargement or enhancement
• Nerve biopsy rarely needed if the diagnosis remains unclear

Treatment & Management

CIDP is treatable. The goals are to stop the immune attack, reduce inflammation, restore nerve function, and prevent disability. Most people respond to one or more first-line therapies. Treatment is individualized and may need adjustment over time. A multidisciplinary team (neurologist, physical therapist, occupational therapist) is often involved.

• Intravenous immunoglobulin (IVIG) or subcutaneous immunoglobulin (SCIG) – common first-line options that modulate the immune system
• Corticosteroids (such as prednisone) – reduce inflammation; used carefully due to long-term side effects
• Plasma exchange (plasmapheresis) – removes harmful antibodies from the blood, often used for severe or refractory cases
• Other immunosuppressants (e.g., azathioprine, mycophenolate, rituximab) if first-line treatments are insufficient or not tolerated
• Supportive care: physical and occupational therapy, pain management, fall prevention, and treatment of any residual weakness or sensory loss
• Regular monitoring of strength, function, and side effects to guide therapy adjustments

Living With It

CIDP is a long-term condition for many people, but remissions and good control are common with treatment. Focus on maintaining strength, preventing complications, and supporting emotional well-being. Stay connected with your care team, report new or worsening symptoms promptly, and consider joining a patient support organization for practical tips and community.

Most people can continue work, family activities, and hobbies with appropriate adaptations and therapy. Energy conservation, adaptive equipment, and a balanced routine help manage fatigue. Mental health support is valuable because chronic illness can affect mood and coping.